Jeremy G. Chadwick, Chief Operating Officer at Kymera Therapeutics, Inc. (KYMR), sold 5,150 shares at $29.30 ($151K) on 2025-05-23, disclosed to the SEC on 2025-05-23.
Open-market sale of $151k KYMR by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.30 | 2,575 | $75K | 50.0% |
| 2 | $29.30 | 2,575 | $75K | 50.0% |
| Total | $29.30 avg | 5,150 | $151K | 100% |
| Filing → |
| KYMR | SELL | 2026-04-16 | $590K | — | Filing → |
| KYMR | SELL | 2026-04-01 | $1.9M | — | Filing → |
| KYMR | SELL | 2026-03-25 | $18.0M | — | Filing → |